Sara S. Rabin-Havt

Submitted by Anonymous (not verified) on
Full Name
Sara S. Rabin-Havt
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Rabin_Havt_Sara_MD_420x504.jpg
Type
Provider
Faculty
First Name
Sara
Last Name
Rabin-Havt
NPI
1194098509
Faculty ID
16281
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Female
Email
sschonfe@montefiore.org
Phone
718-405-8150
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
Reproductive & Medical Genetics
Type
Clinical
Title
Attending Reproductive and Medical Genetics
Type
Clinical
Title
Director, Education, New York Center for Rare Diseases
Tags
me-patientcare-rarediseases
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.845166 40.8462736)
Room
301
Address Line 1
Montefiore Medical Park
Address Line 3
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park
Education and Trainings
Education Type Label
Medical Education
Education Institution
Icahn School of Medicine at Mt. Sinai
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

Reproductive and medical genetics, specifically prenatal and preconception consultation and testing and consultation and testing for hereditary cancer syndromes.

Research Focus

Principal investigator on a multi-center study investigating the genetic etiologies of non-immune fetal hydrops (NIHF). In addition, I participate in studies examining access to genetic consultation and testing pre- and post-pandemic

EMR ID
55649
Biography

<p>Sara Schonfeld Rabin-Havt, MD, FACOG, FACMG is an attending physician and assistant professor in the division of Reproductive and Medical Genetics at Montefiore Einstein. Her clinical focus lies in prenatal and preconception genetic counseling, screening and testing; prenatal diagnosis; evaluation of recurrent pregnancy loss; genetic counseling and testing for hereditary cancer syndromes.</p><p>After earning her Bachelor of Arts from Cornell University (2005) and her Doctor of Medicine from Mt. Sinai School of Medicine (2009), Dr. Rabin-Havt came to Montefiore Einstein to complete residency in Obstetrics &amp; Gynecology and Women&rsquo;s Health (2013). She worked as a generalist in private practice before returning to Montefiore Einstein to complete a residency in medical genetics and genomics (2019).</p><p>Building on her clinical focus, Dr. Rabin-Havt is a principal investigator on a multi-center study investigating the genetic etiologies of non-immune fetal hydrops (NIHF). In addition, she participates in resident, fellow and medical student education and has been inducted into the Leo M. Davidoff Society for Outstanding Achievement in medical student teaching at Einstein. Her work has been published in numerous peer-reviewed journals.</p><p>Dr. Rabin-Havt is a fellow of the American College of Obstetrics and Gynecology (ACOG) and the American College of Medical Genetics (ACMG). She has served as a board member of the NYS Genetics Task Force and a committee member of the American College of Medical Genetics (ACMG) committee on Social, Ethical, and Legal issues (SELI). She was a member of the curriculum committee of the CREOG Cancer Genetics Curriculum which is available to OB/GYN residents nationwide.</p><p>Dr. Rabin-Havt is board certified by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Medical Genetics and Genomics (ABMGG).</p>

Is Open Scheduling
Off

Stuart Packer

Submitted by Anonymous (not verified) on
Full Name
Stuart Packer
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0d90dcb0-3939-11ed-9b41-f32856b0701a.jpg
Type
Provider
Faculty
First Name
Stuart
Last Name
Packer
NPI
1124059621
Faculty ID
13484
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Male
Email
spacker@montefiore.org
Phone
718-405-8505
Titles
Type
Academic
Department
Department of Oncology
Rank
Assistant Professor
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Oncology & Hematology
Type
Clinical
Title
Clinical Director, Medical Oncology Service, Weiler Campus
Tags
me-patientcare-cancer-research-epidemiology
Type
Clinical
Title
Associate Professor of Clinical Medicine
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84607 40.84531)
Address Line 1
1521 jarrett Place
City
Bronx
State
NY
Zip
10461-2606
Location Title
Montefiore M-E Center for Cancer Care
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.845166 40.8462736)
Address Line 1
Montefiore Medical Park
Address Line 3
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park
Education and Trainings
Education Type Label
Medical Education
Education Institution
SUNY Downstate College of Medicine
Education Type Label
Fellowship
Education Institution
Duke University Medical Center
Education Type Label
Residency
Education Institution
Duke University Medical Center
Professional Interests

<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p>
<p>Dr. Packer&rsquo;s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore&rsquo;s Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p>
<p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer, Clinical Cancer Research, British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>

CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

Dr. Packer&rsquo;s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer.

EMR ID
5497
Biography

<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p><p>Dr. Packer&rsquo;s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore's Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p><p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer</em>, <em>Clinical Cancer Research</em>, <em>British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>

Is Open Scheduling
Off

Irina Murakhovskaya

Submitted by Anonymous (not verified) on
Full Name
Irina Murakhovskaya
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f602dc0-4e1f-11ee-8db1-bb4c384b05c4.jpg
Type
Provider
Faculty
First Name
Irina
Last Name
Murakhovskaya
NPI
1235180464
Faculty ID
13953
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Female
Email
imurakho@montefiore.org
Phone
718-920-4137
Titles
Type
Academic
Department
Department of Oncology
Rank
Associate Professor
Division
Hematology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Associate Professor
Division
Oncology & Hematology
Type
Administrative
Title
Chief, Division of Hematology
Tags
me-patientcare-hematology
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84544 40.84518)
Address Line 1
1621 Eastchester Road
City
Bronx
State
NY
Zip
10461-2301
Location Title
Montefiore Medical Group-Comprehensive Family Care Center (CFCC)
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84563 40.84596)
Address Line 1
1575 Blondell Avenue
City
Bronx
State
NY
Zip
10461-2601
Location Title
Montefiore Medical Park at 1575 Blondell
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88133 40.88109)
Address Line 1
3444 Kossuth Avenue
City
Bronx
State
NY
Zip
10467-2241
Location Title
Montefiore Medical Group-Family Care Center (FCC)
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88263 40.87994)
Address Line 1
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore at 60 East 208th Street
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8782381 40.8799784)
Address Line 1
Montefiore Medical Center
Address Line 3
3411 Wayne Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Albert Einstein College of Medicine
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center-AECOM
Professional Interests

<p>Dr. Irina Murakhovskaya is an Assistant Professor of Medicine (Hematology). She completed a medical degree at Albert Einstein College of Medicine and residency and fellowship training at Montefiore Health System. Her clinical interests focus on monoclonal gammopathy, low-grade lymphoma, and hematologic issues in pregnancy.</p>
<p>Dr. Murakhovskaya is currently chairman of the fellowship Clinical Competency Committee and assistant course director for the Albert Einstein of Medicine Hematology Course.&nbsp;</p>

CHAM Provider
Off
Professional Title
M.D.
EMR ID
4308
Is Open Scheduling
Off

Michael Miksa

Submitted by Anonymous (not verified) on
Full Name
Michael Miksa
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Miksa_Michael_MD_2x.jpg
Type
Provider
Faculty
First Name
Michael
Last Name
Miksa
NPI
1881854735
Faculty ID
14249
Clinical Terms
Employment Status
Full Time
Patient Type
Pediatric
Department
einstein-dept-pediatrics
einstein-dept-neurology
Gender
Male
Email
mmiksa@montefiore.org
Phone
718-741-2432
Titles
Type
Academic
Department
Department of Pediatrics
Department Link
Rank
Assistant Professor
Division
Pediatric Critical Care
Type
Academic
Department
The Saul R. Korey Department of Neurology
Department Link
Rank
Assistant Professor
Type
Clinical
Title
Attending Pediatric Intensivist, The Children's Hospital at Montefiore
Type
Clinical
Title
Assistant Professor, Department of Pediatrics, Albert Einstein College of Medicine
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.87885 40.88037)
Address Line 1
3415 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467-2403
Location Title
The Children's Hospital at Montefiore
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8782381 40.8799784)
Address Line 1
Montefiore Medical Center
Address Line 3
3411 Wayne Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Freie Universitat Berlin
Education Type Label
Fellowship
Education Institution
Yale University School of Medicine
Education Type Label
Residency
Education Institution
St. Clemens Hospital
Education Type Label
Residency
Education Institution
SUNY Downstate
CHAM Provider
On
Professional Title
M.D.
Ph.D.
Clinical Focus

Pediatric critical care

EMR ID
5832
Biography

<p>Physician-Scientist, Michael Miksa, MD, PhD received his medical degree from the Free University of Berlin in Germany and his academic degree magna cum laude from The Charit&eacute; &ndash; Universit&auml;tsmedizin Berlin. He completed his pediatric residency training at State University of New York (SUNY) Downstate, a critical care fellowship at Yale and had worked in the pediatric emergency department for the Boston Children&rsquo;s Hospital.</p><p>Dr. Miksa presented his work at several meetings both nationally and abroad and is Site Investigator for NEAR4KIDS, a multi-center quality improvement study to limit adverse events during intubations.</p>

Is Open Scheduling
Off

Ioannis Mantzaris

Submitted by Anonymous (not verified) on
Full Name
Ioannis Mantzaris
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b67e5d80-3938-11ed-a06a-83625b154202.jpg
Type
Provider
Faculty
First Name
Ioannis
Last Name
Mantzaris
NPI
1871865519
Faculty ID
14586
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Male
Email
imantzar@montefiore.org
Phone
718-920-4826
Titles
Type
Academic
Department
Department of Oncology
Rank
Associate Professor
Tags
me-patientcare-cancer-clinical-aids-malignancies
me-patientcare-cancer-clinical-blood-bone-marrow
me-patientcare-cancer-research-therapeutics
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Associate Professor
Division
Oncology & Hematology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Building
Hofheimer Main
Room
100
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
University of Athens Medical School
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Jacobi Medical Center
Education Type Label
Residency
Education Institution
General Hospital of Trikala
Education Type Label
Residency
Education Institution
Agios Savvas Anticancer-Oncology Hospital Athens
CHAM Provider
Off
Professional Title
M.D.
M.S.
EMR ID
57027
Is Open Scheduling
Off

Kenneth G. Liu

Submitted by Anonymous (not verified) on
Full Name
Kenneth G. Liu
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/62a47410-3938-11ed-9b41-f32856b0701a.jpg
Type
Provider
Faculty
First Name
Kenneth
Last Name
Liu
NPI
1174840888
Faculty ID
15135
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Male
Email
kliu@montefiore.org
Phone
718-405-1700
Titles
Type
Academic
Department
Department of Oncology
Rank
Assistant Professor
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Oncology & Hematology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88263 40.87994)
Address Line 1
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore at 60 East 208th Street
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8822305 40.8791652)
Address Line 1
Montefiore Medical Center
Address Line 3
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
University of Cincinnati College of Medicine
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Harbor UCLA Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
57009
Is Open Scheduling
Off

Justin J. Kopa

Submitted by Anonymous (not verified) on
Full Name
Justin J. Kopa
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Kopa_Justin_MD_420x504.jpg
Type
Provider
Faculty
First Name
Justin
Last Name
Kopa
NPI
1790043800
Faculty ID
15796
CMO Specialties
Clinical Terms
Employment Status
Per Diem
Patient Type
Adult
Department
einstein-dept-pediatrics
Gender
Male
Provider Type
Primary Care
Email
jkopa@montefiore.org
Phone
718-741-2453
Titles
Type
Academic
Department
Department of Pediatrics
Department Link
Rank
Assistant Professor
Division
Academic General Pediatrics
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.9013 40.82074)
Address Line 1
871 Prospect Avenue
City
Bronx
State
NY
Zip
10459-3913
Location Title
Montefiore South Bronx Center Children and Families
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.90101 40.82084)
Address Line 1
890 Prospect Avenue
City
Bronx
State
NY
Zip
10459-3978
Location Title
Montefiore South Bronx at 890
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8791698 40.880273)
Room
201
Address Line 1
Montefiore Medical Center
Address Line 2
3415 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
University of Washington Sch of Med, Seattle
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
54643
Is Open Scheduling
Off

Susan D. Klugman

Submitted by Anonymous (not verified) on
Full Name
Susan D. Klugman
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Klugman_Susan_MD_420x504.jpg
Type
Provider
Faculty
Expert
First Name
Susan
Last Name
Klugman
NPI
1649350117
Faculty ID
2154
Employment Status
Full Time
Patient Type
Pediatric
Department
einstein-dept-obstetrics-gynecology-womens-health
einstein-dept-pediatrics
Gender
Female
Email
sklugman@montefiore.org
Phone
718-405-8150
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Professor
Division
Reproductive & Medical Genetics
Type
Academic
Department
Department of Pediatrics
Department Link
Rank
Professor
Type
Clinical
Title
Director, Reproductive and Medical Genetics
Type
Clinical
Title
Program Director, Medical Genetics and Genomics at Montefiore Einstein
Type
Clinical
Title
Professor, Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine
Type
Clinical
Type
Administrative
Title
Director of Reproductive Genetics, Department of Obstetrics & Gynecology and Women's Health
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road -suite 301
City
Bronx
State
NY
Zip
10461-2374
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.845166 40.8462736)
Room
301
Address Line 1
Montefiore Medical Park
Address Line 3
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Albert Einstein College of Medicine
Research Areas
Prenatal Diagnosis
Non Invasive Prenatal Screening
Expanded Carrier Screening
Hereditary Cancer Syndromes
Jewish Genetics
Zika
Genetic Education
Specialties
Expert Tags
Areas of Expertise
Prenatal testing
Genetic causes for diseases
The BRCA gene
Osteoporosis
Expert Summary

<p>Dr. Klugman is a "medical detective" who works to identify the possible genetic risk factors for many inherited diseases. She encourages couples to consider genetic testing even before they get married so they can be as informed as possible when planning their families. Dr. Klugman’s clinical focus is on the evaluation of patients and families at risk for genetic disorders during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies. She also provides evaluations for patients at risk for hereditary cancer syndromes.

Dr. Klugman has appeared on ABC World News Tonight with Diane Sawyer and WABC-TV Ch. 7. She has also been profiled and quoted in numerous articles in the Westchester Journal News.</p>

CHAM Provider
On
Professional Title
M.D.
Clinical Focus

&nbsp;Dr. Klugman&rsquo;s clinical focus is on the evaluation of patients and families at risk for genetic disorders during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies. She also provides evaluations for patients at risk for hereditary cancer syndromes.

Research Focus

Dr. Klugman&rsquo;s research focuses on novel methods for prenatal screening, testing and diagnosis as well as the assessment of new modalities for diagnoses and treatment of hereditary cancer syndromes.

Selected Publications

<p>Syeda M, Upadhyay K, Loke J, <strong>Klugman S</strong>, Pearlman A, Shao Y, Ostrer H,<em> Prediction of breast&nbsp;<em>cancer risk based on flow variant analysis of circulating peripheral blood B cells,&nbsp;</em>Genetics in Medicine, March 16, 2017</em></p>
<p>Aung C, Greb A, Kalia I, Bajaj K, <strong>Klugman S</strong>, <em>Patient Perspectives on Intimate Partner Violence Discussion during Genetic Counseling Sessions</em>, Journal of Genetic Counseling, December 9, 2016</p>
<p>Wiesman C, Rose E, Grant A, Zimlover A, <strong>Klugman S</strong>, Schreiber-Agus N, <em>Experiences from a pilot program bringing BRCA1/2 genetic screening to the U.S. Ashkenazi Jewish population - The BRCAcommunity Initiative: Results and Reflections from Year 1, </em>Genetics in Medicine, October 2016</p>
<p>Gregg A, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, <strong>Klugman S</strong>, Watson MS, <em>Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics</em>, Genetics in Medicine, October 18 2016</p>
<p>Shani H, Goldwaser T, Keating J, <strong>Klugman S, </strong><em>Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center,</em> American Journal of Obstetrics and Gynecology, Jun 2016; 214(6):729.e1-729.</p>
<p>Rose E, Schreiber-Agus N, Bajaj K, <strong>Klugman S</strong>, Goldwaser T. <a href="http://www.ncbi.nlm.nih.gov/pubmed/26354339"><em>Challenges of Pre- and Post-Test Counseling for Orthodox Jewish Individuals in the Premarital Phase.</em></a> Journal of Genetic Counseling. 2016 Feb;25(1):18-24.</p>
<p>Wiesman C, Rose E, <strong>Klugman S</strong>, Schreiber-Agus N. <a href="http://www.ncbi.nlm.nih.gov/pubmed/26611540"><em>From Campers to Counselors: a Resource for Prospective Genetic Counseling Students.</em></a>Journal of Genetic Counseling. 2015 Nov 27</p>
<p>Ferraira, JC, Shreiber-Agus N, Carter SM, <strong>Klugman S,</strong> Grieg AR, Gross SJ <em>Carrier&nbsp;<em>testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze</em>, American Journal of Obstetrics &amp; Gynecology, 2014 Sept (3) 194-204.</em></p>
<p><strong>Klugman S</strong>, Dolan SM. <em>Expanded genetic testing in assisted reproductive technology: lessons learned from prenatal testing</em>. Virtual Mentor 2014 Jan 1;(16)1: 38-42</p>
<p><strong>Klugman S, </strong>Suskin,B, Spencer B, Dar P, Bajaj K, Powers, J, Reichling J, Wasserman D,&nbsp;Dolan S, Merkatz I.&nbsp;<em>Clinical Utility of Chromosomal Microarray Analysis in Prenatal&nbsp;<em>Diagnosis: Report of First 6 Months in Clinical Practice&nbsp;</em>The Journal of Maternal-Fetal and&nbsp;Neonatal Medicine 2013 Nov 26</em></p>
<p><strong>Klugman S,</strong> Schreiber-Agus N, Nazareth S<strong>, </strong>Evans, E<em>Detection of Carriers in the Ashkenazi Jewish Population: An Objective Comparison of High-Throughput Genotyping vs Gene by Gene </em>Genetic Testing and Molecular Biomarkers 2013 Oct;17(10):763-7</p>
<p>Guti&eacute;rrez JF, Bajaj K,&nbsp;<strong>Klugman</strong><strong>&nbsp;</strong><strong>SD</strong>. <em>Prenatal screening for fragile x: carriers, controversies, and counseling. </em>Reviews in Obstetrics and Gynecology 2013;6(1):e1-7</p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rinella%20ES%5BAuthor%5D&amp;ca… ES</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Shao%20Y%5BAuthor%5D&amp;cautho… Y</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Yackowski%20L%5BAuthor%5D&amp;c… L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Pramanik%20S%5BAuthor%5D&amp;ca… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Oratz%20R%5BAuthor%5D&amp;cauth… R</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Schnabel%20F%5BAuthor%5D&amp;ca… F</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Guha%20S%5BAuthor%5D&amp;cautho… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=LeDuc%20C%5BAuthor%5D&amp;cauth… C</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Campbell%20CL%5BAuthor%5D&amp;c… CL</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Klugman%20SD%5BAuthor%5D&amp;ca…; <strong>SD</strong></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Terry%20MB%5BAuthor%5D&amp;caut… MB</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Senie%20RT%5BAuthor%5D&amp;caut… RT</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Andrulis%20IL%5BAuthor%5D&amp;c… IL</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Daly%20M%5BAuthor%5D&amp;cautho… M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=John%20EM%5BAuthor%5D&amp;cauth… EM</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Roses%20D%5BAuthor%5D&amp;cauth… D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Chung%20WK%5BAuthor%5D&amp;caut… WK</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ostrer%20H%5BAuthor%5D&amp;caut… H</a>. <em>Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation</em> Hum Genet 2013 May 132(5) 523-26.</p>
<p class="desc">Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, <strong>Klugman S</strong>, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L. <em>Chromosomal microarray versus karyotyping for prenatal diagnosis. </em>New England Journal of Medicine 2012 Dec &nbsp;&nbsp;&nbsp;6:367(23) 2175-8</p>
<p>Robin,NH, Reid Sutton V, Caldwell J, Jackson J, Irons M, Demmer L, Byers P, Ellison J,&nbsp;Feldman J, Gross S,&nbsp;<strong>Klugman S</strong>, Adam A, Keppler-Noreuil K, Hopkin R, McCandless S,&nbsp;Sharer D, Wiesner G, Pyeritz R, Westerman J&nbsp;&nbsp;&nbsp;&nbsp;<em>The development and implementation of an&nbsp;<em>In-service exam for medical genetics residency programs.&nbsp;</em>Genetics in Medicine 2012 May 14&nbsp;(5):552-7</em></p>
<p>Yachelevich N, Gittler JK, <strong>Klugman S</strong>, Feldman B, Martin J, Brooks&nbsp; SS, Dobkin C, Nolin SL. <em>Terminal deletions&nbsp; of the long arm of chromosome X that include the FMR1 gene in female patients: A case series.</em> American Journal of Medical Genetics A. 2011 Apr;155(4):870-4.</p>
<p class="desc">Gross, SJ, Bajaj K, Garry D, <strong>Klugman S</strong>, Karpel BM, Roe AM Wagner BJ, Zhan J, Apfelroth SD, Schreiber-Agus N: <em>Rapid and novel prenatal molecular assay for detecting aneuploides and microdeletion syndromes</em>. Prenatal Diagnosis 2011 31(3):259-66</p>
<p class="desc">Ram, KT, <strong>Klugman, SD</strong>: <em>Best practices: antenatal screening for Common genetic conditions other than aneuploidy</em>. Current Opinions in Obstetrics and Gynecology 2010 22(2):139-45&nbsp;</p>
<p class="desc"><strong>Klugman, S,</strong> Gross, SJ: Ashkenazi Jewish screening in the twenty-first century. Obstetric and Gynecologic Clinics of North America 2010 37(1): 37-46&nbsp;&nbsp;</p>
<p class="desc">Rybak, EA, Beviliacqua, K, Veit, CR, <strong>Klugman, SD</strong>, Santoro N: <em>Sibling and self ovum donation for sisters with an intermediate FMR1 mutation: what's a program to do. </em>Fertility and Sterility 2009 92(1): 394</p>
<p class="desc"><strong>Klugman, S</strong>, Gross SJ, Khabele D, Liang, J, Lopez-Jones, M, Gross, B, Cordero, DR, Reznik, S: <em>Expression of Keratin 8 and TNF-Related Apoptosis-I Inducing Ligand (TRAIL) in Down Syndrome Placentas</em>. Placenta 2008 29(4):382-4</p>
<p class="desc">Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, <strong>Klugman S</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, TrippT, Bianchi DW, D&rsquo;Alton ME; <em>First and second Trimester screening detection of aneuploides other than Down Syndrome.</em>&nbsp; Obstetrics and Gynecology 2007 110(3):651-7</p>
<p class="desc">Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, KharbutliY, Porter TF, Luthy DA, Comstock CH, Saade GR, <strong>Klugman S</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR Wolfe HM, D&rsquo;Alton ME. <em>Pregnancy loss rates after midtrimester Amniocentesis. </em>Obstetrics and Gynecology. 2006 108:1067-72</p>
<p>Lambert-Messerlian, G., Dugoff, L., Vidaver, J., Canick, J.A., Malone, F.D., Ball, R.H., Comstock, C.H., Nyberg, D.A., Saade, G., Eddleman, K., <strong>Klugman, S</strong>., Craigo, S.D., Timor-Tritsch, I.E., Carr, S.R., Wolfe, H.M. &amp; D&rsquo;Alton, M.E. (2006). <em>First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): A FASTER trial study.</em>&nbsp; Prenatal Diagnosis, 26(8):672-8.</p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retriev… DR, Goldberg Y, Basel D, Kilpatrick MW, <strong>Klugman S</strong>, Tsipouras P, Gross S.</a><em>Prenatal sonographic diagnosis of Grebe syndrome.</em> Journal of Ultrasound in Medicine. 2006 (1):115-8</p>
<p>Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Saade GR, Edelmann KA, <strong>Klugman S</strong>, Timor-Tritsch IE, Craigo SD, Carr SR, Wolfe HM, Bianchi DW, D&rsquo;Alton M<em> Faster Consortium, &ldquo;Impact of maternal age on obstetric outcome.&rdquo; </em>Obstetrics and Gynecology 2005 Vol. 105(5 Pt 1):983-90</p>

EMR ID
3754
Biography

<p>Susan Klugman, MD, FACOG, FACMG, is Director, Reproductive and Medical Genetics, Program Director, Medical Genetics and Genomics Residency and Professor, Obstetrics &amp; Gynecology and Women&rsquo;s Health and Pediatrics at Montefiore Einstein. Her clinical focus is on the evaluation of patients and families at risk for genetic disorders including those patients at risk for hereditary cancer syndromes. She also provides evaluations during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies.</p><p>After completing her Bachelor of Science at Cornell University in 1984, Dr. Klugman attended New York University School of Medicine, earning her Doctor of Medicine in 1988. She pursued her postdoctoral training at Montefiore Einstein and Jacobi Medical Center, completing her obstetrics and gynecology residency in 1992 and serving as administrative chief resident in her final year. In 2002, she continued her medical training at Montefiore Einstein in medical genetics, completing the program in 2004.</p><p>Dr. Klugman&rsquo;s research focuses on novel methods for prenatal screening, testing and diagnosis as well as the assessment of new modalities for the diagnosis and treatment of hereditary cancer syndromes. Her work has been published in peer-reviewed journals, book chapters and other print publications. She was the Reproductive Genetics Editor for <em>Genetics in Medicine</em> and has been a reviewer for journals such as the <em>American Journal of Medical Genetics, Obstetrics and Gynecology and Prenatal Diagnosis</em>. Dr. Klugman has spoken extensively at regional and national medical conferences, including more than 70 international and national invited presentations.</p><p>Dr. Klugman has served on the board of the American College of Medical Genetics since 2015 and will be President from 2023 to 2025. She has completed six-year terms on both the Committee on Genetics of the American Board of Obstetrics and Gynecology and the Residency Review Committee for Medical Genetics for the Accreditation Council of Graduate Medical Education. She is board certified in both obstetrics and gynecology and medical genetics and is listed in several medical directories including <em>Who&rsquo;s Who in Medical Sciences Education</em>, <em>Who&rsquo;s Who in Academic Medicine</em>, <em>New York Magazine</em> Best Doctors list, and Castle Connelly <em>How to Find the Best Metro Area Doctors</em>.</p>

Is Open Scheduling
Off

Kira Gritsman

Submitted by Anonymous (not verified) on
Full Name
Kira Gritsman
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6b993220-5d55-11ef-92db-0be6da54f487.jpg
Type
Provider
Faculty
First Name
Kira
Last Name
Gritsman
NPI
1174598148
Faculty ID
14128
Clinical Terms
Employment Status
part-time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
einstein-dept-cell-biology
Gender
Female
Email
kira.gritsman@einsteinmed.edu
Phone
929-246-6707
Titles
Type
Academic
Department
Department of Oncology
Rank
Associate Professor
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Associate Professor
Division
Oncology & Hematology
Type
Academic
Department
Department of Cell Biology
Department Link
Rank
Associate Professor
Type
Clinical
Title
Assistant Director of Correlative Clinical Research
Type
Administrative
Title
Co-Leader, Montefiore Einstein Comprehensive Cancer Center, Stem Cell & Cancer Biology Program
Tags
me-patientcare-cancer-clinical-aids-malignancies
me-patientcare-cancer-research-stem-cell-cancer-biology
Type
Administrative
Title
Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8459022 40.8504961)
Building
Chanin Building
Room
410A
Address Line 1
Albert Einstein College of Medicine
Address Line 2
Jack and Pearl Resnick Campus
Address Line 3
1300 Morris Park Avenue
City
Bronx
State
NY
Zip
10461
Location Title
Albert Einstein College of Medicine
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
Dana Farber Cancer Institute
Education Type Label
Fellowship
Education Institution
Dana-Farber Cancer Institute
Education Type Label
Residency
Education Institution
Columbia University Medical Center
Professional Interests

<p><strong>The Roles of Signaling Pathways in Adult Blood Development and Leukemia</strong></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">The Gritsman lab studies the signal transduction pathways that affect the early fate decisions of adult hematopoietic stem cells (HSCs) as they progress from an undifferentiated multipotent state to the generation of differentiated blood cells.&nbsp; When these early fate decisions go awry, this can lead to the formation of leukemia-initiating cells. We are interested in</span><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;how signaling pathways affect the self-renewal and differentiation of HSCs and malignant or pre-malignant stem cells in myeloid malignancies, such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN).</span></p>
<p><strong>Roles of the PI3 kinase isoforms in adult blood development</strong></p>
<p>PI3 kinase (PI3K) is a lipid kinase that is important for the regulation of metabolism, the cell cycle, apoptosis, and protein synthesis. &nbsp;In hematopoietic cells, there are four isoforms of the catalytic subunit of PI3K, each encoded by a separate gene. &nbsp;Emerging evidence suggests that these isoforms have unique functions in normal and cancer cells, but may substitute for each other in some contexts.&nbsp; We have generated a series of mouse knockout models that allow us to study the roles of each of these isoforms individually in adult hematopoiesis.&nbsp; For example, we have found that the p110alpha isoform is most important for red cell development, but is not required in normal blood stem cells. We have now also generated compound knockout mice to determine the redundant roles of the PI3K isoforms in blood development. &nbsp;We recently reported that PI3K isoforms play important redundant roles during the hematopoietic stress response, such as after chemotherapy. However, deletion of all 3 Class IA PI3K isoforms leads to a phenotype with impaired HSC differentiation, resembling myelodysplastic syndrome (MDS). We are studying how deletion of PI3K will impact normal HSC function, including self-renewal, proliferation, and differentiation along different blood lineages by affecting processes such as autophagy and epigenetic regulation in HSCs.</p>
<p><strong>Roles of the PI3 kinase isoforms in leukemia</strong></p>
<p>Acute myeloid leukemia (AML) is a genetically diverse disease, but activation of the PI3K pathway has been reported in up to 80% of cases.&nbsp; A subset of AML cell lines and AML patient samples respond to PI3K pathway inhibitors, but it is unclear how patients should be selected for potential response to these inhibitors. &nbsp;We found that RAS-mutated myeloid leukemias are particularly dependent on the p110alpha isoform of PI3K, and that pharmacologic inhibition of p110alpha can be used to treat both RAS-mutated cell lines and RAS-mutated leukemia in mice. Furthermore, we use cell lines, patient samples, and mouse models of leukemia to investigate the mechanisms of resistance to PI3K inhibition, with the goal of identifying new drug targets and designing new combination treatments for leukemia that incorporate PI3K inhibitors.</p>
<p><strong>RON Kinase in Myeloproliferative Neoplasms</strong></p>
<p>The myeloproliferative neoplasms (MPNs) are a group of diseases that are caused by kinase mutations in HSCs, which lead to uncontrolled proliferation of myeloid cells. The Philadelphia chromosome-negative MPNs are characterized by mutations in the JAK/STAT signaling pathway, and respond to JAK inhibitors, but resistance often develops. We recently discovered that the receptor Tyrosine kinase RON can physically interact with JAK2 in MPN cells, leading to potentiation of JAK/STAT signaling in resistant cells. Furthermore, we found that pharmacologic or genetic inactivation of RON can inhibit proliferation of MPN cells and re-sensitize resistant cells to JAK inhibitors.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;"><strong><span style="font-size: 10.5pt; font-family: Verdana, sans-serif; color: #201f1e;">Member of the Cancer Dormancy and Tumor Microenvironment Institute&nbsp;</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">The Gritsman lab&rsquo;s research interests include the contributions of signaling pathways to leukemic and pre-leukemic stem cell dormancy in minimal residual disease, which includes mechanisms of immune evasion. Furthermore, the Gritsman lab is interested in the roles of inflammatory signaling pathways and of the local microenvironment in bone marrow fibrosis, and in the evolution of myeloid neoplasms from the pre-malignant to malignant state. Our major goals are to identify opportunities for therapeutic targeting to prevent the transition from the pre-leukemic state to leukemia, or to eliminate minimal residual disease to prevent relapse.</span></p>

Research Areas
roles of signaling pathways in hematopoietic stem cell self-renewal and differentiation, leukemic stem cells, targeting signaling pathways in hematologic malignancies
CHAM Provider
Off
Professional Title
M.D.
Ph.D.
Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><a name="_GoBack"></a><span style="font-size: 11pt; font-family: Arial, sans-serif;">Ames, K.,&nbsp;<sup>&nbsp;</sup>Kaur,<sup>&nbsp;</sup>I., Shi, Y., Tong, M., Sinclair, T., Hemmati, S., Glushakow-Smith, S.G., Tein,&nbsp;&nbsp;E., Gurska, L., Steidl, U., Dubin, R., Shan, J., Montagna, C., Pradhan, K., Verma, A., and&nbsp;<strong><u>Gritsman, K.</u></strong>, Deletion of PI3-Kinase Promotes Myelodysplasia Through Dysregulation of Autophagy in Hematopoietic Stem Cells,&nbsp;<strong><em>Science Advances</em></strong><em>&nbsp;2023.&nbsp;</em>doi:&nbsp;<a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.o…; target="_blank" rel="noopener"><span style="color: black; text-decoration: none;">10.1126/sciadv.ade8222</span></a><u>,&nbsp;</u>PMID:&nbsp;36812307</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><em><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></em></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Folgado Marco, V., Ames, K., Chuen, J.,&nbsp;<strong><u>Gritsman, K.</u></strong>&nbsp;&amp; Baker, N.,&nbsp;Haploinsufficiency of the essential gene&nbsp;<em>RpS12</em>&nbsp;causes defects in erythropoiesis and hematopoietic stem cell maintenance,&nbsp;<em>&nbsp;<strong>eLife</strong>&nbsp;</em>2023&nbsp;Jun 5;12:e69322. doi: 10.7554/eLife.69322.&nbsp;PMID:&nbsp;37272618</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gurska, L.M., Okabe, R., Schurer, A., Tong, M.M., Soto, M., Choi, D., Ames, K., Glushakow-Smith, S., Montoya, A., Tein, E., Miles, L.A., Cheng, H., Hankey-Giblin, P., Levine, R.L., Goel, S., Halmos, B., and&nbsp;<strong><u>Gritsman, K.</u></strong>&nbsp;Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms,&nbsp;<strong><em>Clinical Cancer Research</em></strong>&nbsp;2022&nbsp;Dec 20:CCR-22-1763. doi: 10.1158/1078-0432.CCR-22-1763. PMID:&nbsp;36537918</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gurska, L., Ames, K., and&nbsp;<strong><u>Gritsman, K</u></strong>, Signaling Pathways in Leukemic Stem Cells,&nbsp;</span><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #333333; letter-spacing: 0.2pt; background-color: #fcfcfc;">In: Zhang H., Li S. (eds) Leukemia Stem Cells in Hematologic Malignancies.&nbsp;<strong>Advances in Experimental Medicine and Biology</strong>, vol 1143. Springer, Singapore</span><span style="font-size: 11pt; font-family: Arial, sans-serif;">, July 24, 2019, doi:&nbsp;<a href="https://doi.org/10.1007/978-981-13-7342-8_1"><span style="color: black; letter-spacing: 0.2pt; background-color: #fcfcfc; text-decoration: none;">https://doi.org/10.1007/978-981-13-7342-8_1</span></a><span style="letter-spacing: 0.2pt; background-color: #fcfcfc;">;&nbsp;</span>PMID:&nbsp;31338813, PMCID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7249489/&quot; target="_blank" rel="noopener"><span style="color: black; text-decoration: none;">PMC7249489</span></a></span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Hemmati, S., Sinclair, T., Tong, M., Bartholdy, B., Okabe, R.O., Ames, K., Ostrodka, L., Haque, T., Kaur, I., Mills, T. S., Agarwal, A., Pietras, E.M., Zhao, J.J., Roberts, T.M., and&nbsp;<strong><u>Gritsman, K.</u></strong>, PI3 kinase alpha and delta promote hematopoietic stem cell activation,&nbsp;<strong><em>JCI Insight&nbsp;</em></strong>2019&nbsp;doi.org/10.1172/jci.insight.125832</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Mitchell, K., Barreyro, L., Todorova, T., Taylor, S., Antony-Debre, I., Narayanagari, S., Carvajal, L., Leite, J., Piperdi, Z., Pendurti, G., Mantzaris, I., Paietta, E., Verma, A.,&nbsp;<strong><u>Gritsman, K.,&nbsp;</u></strong>and Steidl, U. IL1RAP potentiates multiple oncogenic signaling pathways in AML,&nbsp;<strong><em>Journal of&nbsp;Experimental Medicine</em></strong><em>.&nbsp;</em>2018 May 17. doi: 10.1084/jem.20180147,&nbsp;PMID: 29773641</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Hemmati, S., Haque, T., and&nbsp;<strong><u>Gritsman, K</u>,&nbsp;</strong>Inflammatory Signaling Pathways in Pre-leukemic and Leukemic Stem Cells,&nbsp;<strong><em>Frontiers in Oncology</em></strong><em>&nbsp;</em>2017 Nov 13;7:265. doi: 10.3389/fonc.2017.00265</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Bhagat, T.D., Chen, S., Bartenstein, M., Barlowe, A.T., Von Ahrens, D., Choudhary, G.S., Tivnan, P., Amin, E., Marcondes, M., Sanders, M.A., Hoogenboezem, R.M., Kambhampati, S., Ramanchandra, N., Mantzaris, I., Sukrithan, V., Laurence, R., Lopez, R. Bhagat, P., Giricz, O., Sohal, D., Wickrema, A., Yeung, C.,&nbsp;<strong><u>Gritsman, K.,</u></strong>&nbsp;Aplan, P., Hochedlinger, K., Yu, Y., Pradhan, K., Zhang, J., Greally, J.M., Mukherjee, S., Pellagatti, A., Boultwood, J., Will, B., Steidl, U., Raaijmakers, M.H.G.P., Deeg, H.J., Kharas, M.G. and Verma, A. Epigenetically Aberrant Stroma in MDS Propagates Disease Via Wnt/b-Catenin Activation, 2017&nbsp;<strong><em>Cancer Research</em></strong>&nbsp;2017 Jul 6. pii: canres.0282.2017. doi: 10.1158/0008-5472</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Yuzugullu, H., Baitsch, L., Von, T., Steiner, A., Tong, H., Ni, J., Clayton, L., Bronson, R., Roberts, T.,&nbsp;<strong><u>Gritsman, K</u></strong><u>.</u>, and Zhao, J.J. A p110b-Rac signaling loop mediates Pten-loss-induced perturbation of hematopoiesis and leukemogenesis.&nbsp;<strong><em>Nature Communication</em></strong><em>s&nbsp;</em>October 7,2015, doi:10.1038/NCOMMS9501</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Yoda, A., Adelmant, G., Tamburini, J., Chapuy, B., Shindoh, N., Yoda, Y., Weigert, O., Kopp, N., Wu, S-C., Kim, S., Liu, H., Tivey, T., Christie, A.L.,&nbsp;<strong><u>Gritsman, K.</u></strong>,&nbsp; Gotlib, J., Deininger, M., Turley, S., Tyner, J., Marto, J., Weinstock, D.M., and Lane, A.A. Mutations in G-protein beta subunits promote transformation and kinase inhibitor resistance&nbsp;<strong><em>Nature Medicine</em></strong><em>&nbsp;</em>2015 (1):71-5.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gritsman, K</span></u></strong><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">.</span></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Yuzugullu, H., Von, T., Yan, H., Clayton, L., Fritsch, C., Maira, S.-M., Hollingworth, G., Choi, C., Khandan, T., Paktinat, M., Okabe, R.O., Roberts, T.M., and Zhao, J.J. &nbsp;Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110alpha<strong>.&nbsp;<em>Journal of Clinical Investigation&nbsp;</em></strong>2014;124(4):1794&ndash;1809.&nbsp;http://www.jci.org/articles/view/69927</span></p&gt;
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Kharas, M.G. and&nbsp;<strong><u>Gritsman, K</u></strong>. Akt: A Double-Edged Sword for Hematopoietic Stem Cells.&nbsp;<strong><em>Cell Cycle</em>&nbsp;</strong>2010; Vol 9; Issue 7</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Kharas, M.G., Okabe, R., Ganis, J.J., Gozo,M., Khandan,T., Paktinat, M., Gilliland, D.G., and&nbsp;<strong><u>Gritsman, K</u>.</strong>&nbsp;Constitutively Active AKT Depletes Hematopoietic Stem Cells and Induces Leukemia in Mice.&nbsp;<strong><em>Blood&nbsp;</em></strong>2010; 115(7): 140615&nbsp;http://www.bloodjournal.org/content/115/7/1406</span></p&gt;
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-family: 'Times New Roman', serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>

EMR ID
73180
Is Open Scheduling
Off

Samuel V. Gorstein

Submitted by Anonymous (not verified) on
Full Name
Samuel V. Gorstein
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Gorstein_Samuel_V_MD_2x.jpg
Type
Provider
Faculty
First Name
Samuel
Last Name
Gorstein
NPI
1285878652
Faculty ID
15800
Clinical Terms
Employment Status
Full Time
Patient Type
Pediatric
Department
einstein-dept-pediatrics
Gender
Male
Email
sgorstei@montefiore.org
Phone
718-741-2436
Titles
Type
Academic
Department
Department of Pediatrics
Department Link
Rank
Assistant Professor
Division
Pediatric Critical Care
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.87885 40.88037)
Address Line 1
3415 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467-2403
Location Title
The Children's Hospital at Montefiore
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8790253 40.8803163)
Address Line 1
Children's Hospital at Montefiore
Address Line 2
3415 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Children's Hospital at Montefiore
Education and Trainings
Education Type Label
Medical Education
Education Institution
University of Massachusetts School of Medicine
Education Type Label
Fellowship
Education Institution
Massachusetts General Hospital
Education Type Label
Residency
Education Institution
Baystate Medical Center
CHAM Provider
On
Professional Title
M.D.
EMR ID
12106
Biography

<p>Samuel Gorstein, MD, is Director, Resident Education, Pediatric Intensive Care Unit (PICU) at the Children&rsquo;s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Gorstein&rsquo;s clinical focus is on the care of critically ill infants, children and adolescents, focusing on conditions requiring intensive monitoring, life support and complex interventions, such as respiratory failure, sepsis, trauma and post-surgical recovery.
</p><p>After obtaining a Bachelor of Science in Biophysics from Brown University, Dr. Gorstein attended the University of Massachusetts Medical School, where he received his Doctor of Medicine in 2009. He then began his postgraduate training with an internship and residency in Pediatrics at Baystate Medical Center from 2009 to 2012. In 2015, he completed a fellowship in Pediatric Critical Care at Massachusetts General Hospital. </p><p>Dr. Gorstein oversees resident education in the PICU and has developed a didactic curriculum for residents rotating through the PICU at CHAM. His research aligns with his clinical expertise, and his work has been shared through peer-reviewed publications, invited presentations, abstracts, and poster presentations at professional meetings. </p><p>Dr. Gorstein is board-certified in Pediatrics and Pediatric Critical Care Medicine. He is a member of the American Academy of Pediatrics and the Society of Critical Care Medicine.

</p>

Is Open Scheduling
Off
Subscribe to Sickle Cell Disease